RSS Feed For (NY:AZN)

ASTRAZENECA PLC (NY:AZN)

44.82 0.37 (0.82%)
ASTRAZENECA PLC (NY:AZN) Delayed :
Previous Close $45.19    52 Week High $47.61 
Open $44.39    52 Week Low $29.96 
Day High $44.82    P/E N/A 
Day Low $44.36    EPS $0.00 
Volume 1,304,437       
More AZN Info: Chart SEC Filings Profile Historical Options

AstraZeneca plc Summary

AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. Its products include Arimidex for hormonal breast cancer; Crestor that provides treatment for managing cholesterol levels; Nexium for acid-related diseases; Seroquel, an atypical anti-psychotic therapy for treating schizophrenia and bipolar mania; and Symbicort for the maintenance treatment of asthma in ...more

Executives

David Brennan - CEO, Director

Links

http://www.astrazeneca.com/


What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
BMY 12 NVS 7
GSK 7 SNY 6
ABT 6 LLY 5
NKTR 5 MYL 5
TRGT 5 XOM 4
EK 4 CL 4
View All Friends, Peers and Foes

Entities who have mentioned AZN

View All Entities

View All Major News StreetInsider.com Major News for AZN

Oct 29, 2009 07:02 AM AstraZeneca plc (AZN) Tops Q3 EPS by 30c
Jul 30, 2009 07:14 AM AstraZeneca (AZN) Tops Q2 EPS by 24c; Guides Higher
View All Major News

View All ReportsStreetInsider.com Reports on AZN

Nov 19, 2009 07:53 AM AstraZeneca (AZN) Submits NDA to U.S. FDA for Ticagrelor
Nov 16, 2009 11:10 AM Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
Nov 16, 2009 07:04 AM Deutsche Bank Initiates Coverage on AstraZeneca (AZN) with a Hold
Nov 12, 2009 07:55 AM Barclays Starts NVO, SNY at Overweight, GSK, AZN at Equalweight, NVS at Underweight
Nov 9, 2009 11:14 AM Notable Analyst Rating Changes 11/09: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
View All Reports

View All Press ReleasesCompany Press Releases on AZN

Nov 20, 2009 07:46PM U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
Nov 20, 2009 10:30AM AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured
Nov 19, 2009 02:00AM AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
Nov 18, 2009 09:15AM Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body
Nov 18, 2009 08:45AM Harte-Hanks and MedImmune Win Medical Marketing & Media Gold Award
View All Press Releases

StreetInsider Reports on AZN by Category

View All BlogsBlogs on AZN

Nov 20, 2009 08:24 AM BioMed News Bytes: AstraZeneca, Delcath, Unilife
Nov 19, 2009 03:03 PM Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
Nov 16, 2009 12:26 PM Direction of Cholesterol Debate Could Benefit Abbott Labs
Nov 16, 2009 12:23 PM 13 British ADRs Increasing Dividend Payments
Nov 16, 2009 11:55 AM Analyst upgrades, downgrades and initiations: DLTR, JCP, JWN, LEA, RIMM, S ...
View All Blogs

View All FilingsSEC Filings on AZN

Oct 7, 2009 02:23PM Form 6-K ASTRAZENECA PLC For: Oct 02
View All Filings

Comments on recent AZN articles

Henry
on Aug 10, 2009
at 12:54 PM Azn Azn looks tasty at these levels!!!
Article: Seattle Genetics (SGEN) Said Milestone Triggered In MedImmune Collaboration
Thomas G Iacono
on Mar 18, 2008
at 09:51 AM Lifecell (LIFC) It was my understanding, that PFE was interested in Lifecell take over. Is this true?
Article: Shire plc (SHPGY) Higher On AstraZeneca Takeover Rumors

Comments on AZN

nike dunks
at Oct 31, 2009 01:41 AM discount nike dunks [url=http://www.likedunksb.com]nike sb[/url],[url=http://www.likedunksb.com]discount nike dunks[/url]
nike dunks
at Oct 31, 2009 01:39 AM discount nike dunks nike sb,discount nike dunks